Please use this identifier to cite or link to this item: https://bura.brunel.ac.uk/handle/2438/34003
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPokhrel, Subhash-
dc.contributor.authorHanney, Stephen-
dc.date.accessioned2026-10-15T09:12:03Z-
dc.date.available2026-10-15T09:12:03Z-
dc.date.issued2026-09-21-
dc.identifier.citationPokhrel, S. and Hanney, S. (2026) 'ESIC Series: Paper 9 Estimating initial costs of Evidence Synthesis Infrastructure Collaborative solutions: assumptions and overall results', Journal of Clinical Epidemiology, 0(in press, pre-proof), 112524, pp. 1–50. doi: 10.1016/j.jclinepi.2026.112524.en_GB
dc.identifier.issn0895-4356-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/34003-
dc.description.abstractAim: To estimate the initial costs of implementing the Evidence Synthesis Infrastructure Collaborative (ESIC) solutions and therefore provide funders with a costed menu of options for strengthening global evidence synthesis systems. Background: ESIC was established to enhance the timeliness, relevance, and affordability of evidence synthesis worldwide. Five Working Groups and a Governance Planning Group were tasked with identifying priority solutions to address systemic gaps in infrastructure, capacity, and governance. We were tasked with costing these solutions from a funder’s perspective to inform strategic investment decisions. Methods: We followed a structured approach with planning of the costing occurring concurrently with the solutions being identified by the groups. We identified resource requirements, measured quantities, and applied unit costs. Inputs included personnel, tools, and system requirements, with indirect costs set at 20% of direct costs and an additional 5% for monitoring, evaluation, and learning. Data were gathered through resource-use questionnaires, literature reviews, and consultations with ESIC groups. Salary costs were estimated using a 3×3 matrix of seniority and geographic bands (Global North; Global South—high/upper-middle income; Global South—low/lower-middle income). Sensitivity analyses addressed uncertainties, particularly in salary assumptions. A separate costing exercise was conducted for a Vanguard Suite, a prioritised collection of 100 living evidence syntheses. Results: The total estimated cost for all 40 solutions identified by the groups was US$278.3 million (range: US$257.2–299 million). Employment costs accounted for the largest share, with 80% of staff time and 78% of senior roles allocated to the Global South, reflecting ESIC’s equity goals. Individual group costs ranged from US$9.1 million (Governance) to US$70.5 million (Data solutions). The suite of living evidence syntheses was costed at US$19.2 million. Conclusion This costing exercise provides transparent, equity-focused information to assist funders when selecting scalable solutions aligned with ESIC’s mission. While estimates involve assumptions, they offer a pragmatic basis for investment planning and demonstrate ESIC’s commitment to affordability, inclusivity, and global impact.en_GB
dc.description.sponsorshipWellcome Trust.en_GB
dc.description.sponsorshipWellcome Trust grant [323143/Z/24/Z Recipient Mrs. Fiona Campbell].-
dc.format.extentpp. 1–50-
dc.format.mediumPrint-Electronic-
dc.languageEnglishen_GB
dc.language.isoenen_GB
dc.publisherElsevieren_GB
dc.rightsRe-use licence for this version: Creative Commons Attribution 4.0 International-
dc.rightsLicence for published version: Creative Commons Attribution 4.0 International-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectcosten_GB
dc.subjectESICen_GB
dc.subjectevidence synthesisen_GB
dc.subjectevidence ecosystemen_GB
dc.subjectliving evidence synthesesen_GB
dc.subjectpolicy informed decision makingen_GB
dc.subject.other01 Mathematical Sciences-
dc.subject.other11 Medical and Health Sciences-
dc.subject.otherEpidemiology-
dc.titleESIC Series: Paper 9 Estimating initial costs of Evidence Synthesis Infrastructure Collaborative solutions: assumptions and overall resultsen_GB
dc.typeArticleen_GB
dc.date.dateAccepted2026-09-14-
dc.identifier.doihttps://doi.org/10.1016/j.jclinepi.2026.112524-
dc.relation.isPartOfJournal of Clinical Epidemiologyen_GB
pubs.publication-statusPublished-
pubs.volume00-
dc.identifier.eissn1878-5921-
dc.rights.licensehttps://creativecommons.org/licenses/by/4.0/legalcode.en-
dcterms.dateAccepted2026-09-14-
dcterms.descriptionWhat is new? • Key Findings: Initial costing figures were produced for all 40 ESIC proposed solutions. • What this adds to what was known: No such previous estimates were available. • What is the implication and what should change now: These initial costing estimates could help to inform the work of the ESIC Funders’ Interest Group, a group of potential funders.en_GB
dcterms.issued2026-09-21-
dc.date.updated2026-10-15T09:07:20Z-
dc.rights.holderThe Author(s)-
dc.contributor.orcidPokhrel, Subhash [0000-0002-1009-8553]-
dc.contributor.orcidHanney, Stephen [0000-0002-7415-5932]-
dc.identifier.number112524-
Appears in Collections:Health Economics Research Group (HERG)
Department of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2026 The Author(s). Published by Elsevier Inc. This is an open access article under a Creative Commons license (https://creativecommons.org/licenses/by/4.0/).1.38 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons